Stay updated on Risankizumab in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Ulcerative Colitis Clinical Trial page.

Latest updates to the Risankizumab in Ulcerative Colitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.3.3 was added and the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed, these are administrative footer updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe Record History now includes an added revision entry for v3.3.2 and removes the v3.2.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page no longer displays the government funding and NIH operating status notice. This change does not affect the clinical trial data or submission process.SummaryDifference0.2%

- Check61 days agoChange DetectedVersion history shows minor metadata updates and intermittent IPDSharing tagging; core study information such as design and outcomes remains unchanged.SummaryDifference0.0%

- Check90 days agoChange Detected- Added a prominent operations/status notice and updated to v3.2.0. - Removed reference to v3.1.0.SummaryDifference6%

- Check97 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Risankizumab in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Ulcerative Colitis Clinical Trial page.